Hinge Health, Inc.(HNGE)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,744 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
HNGE Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Hinge Health, Inc. (HNGE), a Technology sector company. 13F Pro's AI-powered ranking engine scores HNGE at 44.9/100 on a 32-signal composite quality model, placing it at rank #1,744 of 2,879 stocks — the bottom half of the AI-ranked universe. HNGE scores in the top quartile across institutional flow (95.9), revenue growth (94.9). Areas of concern include profitability (30.0) and balance sheet strength (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 3.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Hinge Health, Inc. reports quarterly revenue of $182.3M, net income of $35.1M, free cash flow of $43.0M. Top institutional holders of HNGE by reported 13-F value include Insight Holdings Group,, 11.2 Capital Management,, Deer Management Co., based on the most recent SEC filings. HNGE trades on the NYSE exchange and files with the SEC under CIK 1673743. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HNGE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Hinge Health, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$182.3M
Net Income
Q1 2026
$35.1M
Free Cash Flow
Q1 2026
$43.0M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+50.6% YoYNet Income
-4326.9% YoYOperating Income
-1612.2% YoYEPS (Diluted)
-783.0% YoYTotal Assets
+10.6% YoYOp. Cash Flow
+249.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $587.9M +50.6% | $390.4M +33.4% | $292.7M | — |
| Net Income | $-528.3M -4326.9% | $-11.9M +89.0% | $-108.1M | — |
| Operating Income | $-546.4M -1612.2% | $-31.9M +75.6% | $-130.5M | — |
| EPS (Diluted) | $-7.77 -783.0% | $-0.88 +89.4% | $-8.31 | — |
| Total Assets | $744.8M +10.6% | $673.3M | — | — |
| Operating Cash Flow | $171.4M +249.9% | $49.0M +176.7% | $-63.9M | — |
Get alerted when HNGE's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Hinge Health, Inc. including:
Top Institutional Holders of HNGE
Insight Holdings Group, LLC
$361.5M9,375,164 sh11.2 Capital Management, LLC
$142.8M3,704,524 shDeer Management Co. LLC
$101.6M2,633,707 shBIT Capital GmbH
$89.1M2,309,797 shRTW INVESTMENTS, LP
$74.4M1,930,000 shFULLER & THALER ASSET MANAGEMENT, INC.
$63.8M1,655,198 shArrowMark Colorado Holdings LLC
$60.7M1,575,283 shBRAIDWELL LP
$56.1M1,455,123 shVANGUARD PORTFOLIO MANAGEMENT LLC
$54.4M1,410,687 shAMERICAN CENTURY COMPANIES INC
$50.1M1,299,332 sh
| Fund | Value | Shares |
|---|---|---|
| Insight Holdings Group, LLC | $361.5M | 9,375,164 |
| 11.2 Capital Management, LLC | $142.8M | 3,704,524 |
| Deer Management Co. LLC | $101.6M | 2,633,707 |
| BIT Capital GmbH | $89.1M | 2,309,797 |
| RTW INVESTMENTS, LP | $74.4M | 1,930,000 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $63.8M | 1,655,198 |
| ArrowMark Colorado Holdings LLC | $60.7M | 1,575,283 |
| BRAIDWELL LP | $56.1M | 1,455,123 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $54.4M | 1,410,687 |
| AMERICAN CENTURY COMPANIES INC | $50.1M | 1,299,332 |
More Technology Companies
View all Technology →Put HNGE on your watchlist
Track score changes the day Hinge Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HNGE a good stock to buy?
13F Pro's AI-powered analysis of Hinge Health, Inc. (HNGE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HNGE are available on the HNGE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own HNGE?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HNGE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Hinge Health, Inc.'s investment landscape.